Antibiotics Usage and Intestinal Microbiota

Abstract

Since the discovery of penicillin, antibiotics have made significant contributions to the treatment of infections in humans. However, as antibiotics are effective not only against pathogenic bacteria but also against all bacterial species that comprise the normal microbiota within the intestine, they can disrupt the balance in the composition of the intestinal microbiota, which causes antibiotic-associated diarrhea (AAD). In particular, infections caused by Clostridium difficile, a pathogenic bacterium known to cause AAD, can lead to pseudomembranous colitis or, in severe cases, death. AAD is primarily treated by halting the administration of the antibiotic thought to be causing the symptoms. After a diagnosis of C. difficile infection is confirmed, if symptoms persist and the patient's condition worsens despite ceasing the administration of the causative antibiotic, the administration of metronidazole or vancomycin may be considered. Moreover, several probiotics have been considered effective in the prevention and treatment of AAD.

Keywords

antibiotics - antibiotic-associated diarrhea - Clostridium difficile - probiotics

• References

• 1 Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361 (9356) 512-519
• 2 Steinhoff U. Who controls the crowd? New findings and old questions about the intestinal microflora. Immunol Lett 2005; 99 (1) 12-16
• 3 Suau A, Bonnet R, Sutren M , et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65 (11) 4799-4807
• 4 Bonnet R, Suau A, Doré J, Gibson GR, Collins MD. Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs. Int J Syst Evol Microbiol 2002; 52 (Pt 3): 757-763
• 5 Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346 (5) 334-339
• 6 Zwiener RJ, Belknap WM, Quan R. Severe pseudomembranous enterocolitis in a child: case report and literature review. Pediatr Infect Dis J 1989; 8 (12) 876-882
• 7 Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330 (4) 257-262
• 8 Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004; 18 (2) 337-352
• 9 Vedantam G, Hecht DW. Antibiotics and anaerobes of gut origin. Curr Opin Microbiol 2003; 6 (5) 457-461
• 10 Doron SI, Hibberd PL, Gorbach SL. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol 2008; 42 (Suppl. 02) S58-S63
• 11 Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46 (Suppl. 01) S12-S18
• 12 Turck D, Bernet JP, Marx J , et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003; 37 (1) 22-26
• 13 Corrêa NB, Péret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005; 39 (5) 385-389
• 14 McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162 (3) 678-684
• 15 Barbut F, Meynard JL, Guiguet M , et al. Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16 (3) 176-181
• 16 Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981; 81 (1) 5-9
• 17 Kato H, Kato N, Watanabe K , et al. Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J Clin Microbiol 1994; 32 (9) 2067-2070
• 18 Nakamura S, Mikawa M, Nakashio S , et al. Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25 (4) 345-351
• 19 Aronsson B, Möllby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985; 151 (3) 476-481
• 20 Lima AA, Innes Jr DJ, Chadee K, Lyerly DM, Wilkins TD, Guerrant RL. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine. Lab Invest 1989; 61 (4) 419-425
• 21 Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996; 60 (1) 167-215
• 22 Alfa MJ, Kabani A, Lyerly D , et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38 (7) 2706-2714
• 23 McDonald LC, Killgore GE, Thompson A , et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353 (23) 2433-2441
• 24 Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7 (7) 526-536
• 25 Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122 (6) 1266-1270
• 26 Deshpande A, Pant C, Anderson MP, Donskey CJ, Sferra TJ. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr Infect Dis J 2013; 32 (10) 1138-1140
• 27 Kim J, Shaklee JF, Smathers S , et al. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31 (2) 134-138
• 28 Garimella PS, Agarwal R, Katz A. The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature. J Postgrad Med 2012; 58 (3) 194-198
• 29 Bélanger SD, Boissinot M, Clairoux N, Picard FJ, Bergeron MG. Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol 2003; 41 (2) 730-734
• 30 van den Berg RJ, Bruijnesteijn van Coppenraet LS, Gerritsen HJ, Endtz HP, van der Vorm ER, Kuijper EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol 2005; 43 (10) 5338-5340
• 31 Schutze GE, Willoughby RE ; Committee on Infectious Diseases; American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics 2013; 131 (1) 196-200
• 32 Shannon-Lowe J, Matheson NJ, Cooke FJ, Aliyu SH. Prevention and medical management of Clostridium difficile infection. BMJ 2010; 340: c1296
• 33 Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc 2012; 87 (11) 1106-1117
• 34 Zhao S, Ghose-Paul C, Zhang K, Tzipori S, Sun X. Immune-based treatment and prevention of Clostridium difficile infection. Hum Vaccin Immunother 2014; 10 (12) 3522-3530
• 35 Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16 (4) 658-672
• 36 Quigley EM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res 2010; 61 (3) 213-218
• 37 Makarova K, Slesarev A, Wolf Y , et al. Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A 2006; 103 (42) 15611-15616
• 38 Schell MA, Karmirantzou M, Snel B , et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A 2002; 99 (22) 14422-14427
• 39 Kurugöl Z, Koturoğlu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005; 94 (1) 44-47
• 40 Seki H, Shiohara M, Matsumura T , et al. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. Pediatr Int 2003; 45 (1) 86-90
• 41 McFarland LV, Surawicz CM, Greenberg RN , et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90 (3) 439-448
• 42 Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979; 36 (6) 754-757
• 43 Clements ML, Levine MM, Ristaino PA, Daya VE, Hughes TP. Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease. Prog Food Nutr Sci 1983; 7 (3–4) 29-37
• 44 Armuzzi A, Cremonini F, Bartolozzi F , et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15 (2) 163-169
• 45 Johnston BC, Vohra S. Does Lactobacillus GG prevent antibiotic-associated diarrhea in children?: Part B: Clinical commentary. Paediatr Child Health (Oxford) 2005; 10 (3) 170-171
• 46 Johnston BC, Cramer K, Vohra S. Does Lactobacillus GG prevent antibiotic-associated diarrhea in children?: Part A: Evidence-based answer and summary. Paediatr Child Health (Oxford) 2005; 10 (3) 169-171
• 47 Wunderlich PF, Braun L, Fumagalli I , et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17 (4) 333-338
• 48 Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149 (3) 367-372
• 49 Hempel S, Newberry SJ, Maher AR , et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18) 1959-1969
• 50 Johnson S, Maziade PJ, McFarland LV , et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics?. Int J Infect Dis 2012; 16 (11) e786-e792